Structures by: Ranjithkumar R.
Total: 6
6a,6b,7,11a-Tetrahydro-6<i>H</i>,9<i>H</i>-spiro[chromeno[3',4':3,4]pyrrolo[1,2-<i>c</i>]thiazole-11,3'-indoline]-2',6-dione
C20H16N2O3S
Acta Crystallographica Section E (2019) 75, 2 246-250
a=11.3058(9)Å b=10.0905(8)Å c=15.1957(12)Å
α=90° β=101.0720(10)° γ=90°
5'-Methyl-6a,6b,7,11a-tetrahydro-6<i>H</i>,9<i>H</i>-spiro[chromeno[3',4':3,4]pyrrolo[1,2-<i>c</i>]thiazole-11,3'-indoline]-2',6-dione
C21H18N2O3S
Acta Crystallographica Section E (2019) 75, 2 246-250
a=8.3648(5)Å b=9.7648(6)Å c=11.9677(7)Å
α=112.6220(10)° β=99.3880(10)° γ=91.8850(10)°
3,5-Bis(4-methylbenzylidene)-4-oxopiperidine-1-carbonitrile
C22H20N2O
Acta Crystallographica Section E (2007) 63, 9 o3749-o3749
a=9.1976(2)Å b=9.5012(2)Å c=10.9418(3)Å
α=104.03(2)° β=95.0800(10)° γ=108.730(10)°
1-(4-Chlorophenyl)-8-(4-fluorophenyl)-4-[(<i>E</i>)-(4- fluorophenyl)methylidene]-6-methyl-4,5,6,7,7a,8-hexahydro- 1,2,4-oxadiazolo[5,4-<i>d</i>]pyrido[3,4-<i>c</i>][1,5]benzothiazepine
C33H26ClF2N3OS
Acta Crystallographica Section E (2007) 63, 11 o4268-o4268
a=10.836(5)Å b=11.366(4)Å c=23.100(3)Å
α=90.0° β=92.630(10)° γ=90.0°
8-[(<i>E</i>)-4-Methoxybenzylidene]-4-(4-Methoxyphenyl)-3- (3-phenyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydro-4<i>H</i>-chromen-2-amine
C32H29N3O4
Acta Crystallographica Section E (2007) 63, 9 o3750-o3750
a=10.5014(3)Å b=11.3187(4)Å c=11.6458(4)Å
α=91.07(2)° β=98.45(2)° γ=104.10(3)°
4'-(2,4-Dichlorophenyl)-1,1'-dimethylpiperidine-3-spiro-3'- pyrrolidine-2'-spiro-3''-indoline-4,2''-dione
C23H23Cl2N3O2
Acta Crystallographica Section E (2010) 66, 3 o717
a=7.9398(2)Å b=10.8747(3)Å c=13.5367(4)Å
α=66.561(2)° β=77.8730(10)° γ=83.203(2)°